Skip to main content
. 2013 Mar;131(3):e709–e717. doi: 10.1542/peds.2012-1883

FIGURE 1.

FIGURE 1

A, CE acceptability curves for all asthma patients. B, Patients with persistent asthma only. CE acceptability curves present probability of SBAT being cost-effective at various values of 1 SFD. NMB, incremental net monetary benefit, the difference between the benefit of the SBAT expressed in monetary terms and the cost of the intervention.